Literature DB >> 32385484

Comparison of the shortened and standard saline infusion tests for primary aldosteronism diagnostics.

Kaoru Yamashita1, Midori Yatabe2, Yasufumi Seki1, Kanako Bokuda1, Daisuke Watanabe1, Satoru Shimizu3, Satoshi Morimoto1, Atsuhiro Ichihara1.   

Abstract

The saline infusion test (SIT) is widely used to confirm PA, but some patients may not tolerate the standard loading volume of 2 L saline over 4 h. The shortened SIT, loading only 1 L saline over 2 h, is suggested to be useful and would be more acceptable if the diagnostic utility of the shortened SIT is comparable to that of the standard SIT. We compared the diagnostic values of the plasma aldosterone concentration after 2 h of 1 L saline loading (2 h PAC) and that after 4 h of 2 L saline loading (4 h PAC) for the prediction of unilateral aldosterone hypersecretion and postoperative outcome. This retrospective, single-center study involved 555 PA-suspected patients who underwent SIT, 153 patients with adrenal vein sampling (AVS) results, and 37 patients with a 1-year postoperative evaluation. To detect the Japanese cutoff of 4 h PAC > 60 pg/mL, a 2-h PAC Youden Index at 66 pg/mL showed 91% sensitivity and 75% specificity. For unilateral aldosterone hypersecretion, the sensitivity and specificity of 2 h PAC were not inferior to those of 4 h PAC by Markov chain Monte Carlo (MCMC) methods. The sensitivity and specificity of 2 h PAC for postoperative reduction of anti-hypertensive drugs were also not inferior to those of 4 h PAC. Although using the 2 h PAC > 66 pg/mL cutoff may increase false positives for PA diagnosis, the shortened SIT, possibly using a cutoff value higher than 66 pg/mL, may be as useful as the standard SIT for selecting PA patients for AVS and to predict postoperative outcomes with reduced burden on patients.

Entities:  

Keywords:  adrenal vein sampling; adrenalectomy; hypertension; primary aldosteronism

Year:  2020        PMID: 32385484     DOI: 10.1038/s41440-020-0454-9

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  17 in total

1.  Shortened saline infusion test for subtype prediction in primary aldosteronism.

Authors:  Kazutaka Nanba; Mika Tsuiki; Hironobu Umakoshi; Aya Nanba; Yuusuke Hirokawa; Takeshi Usui; Tetsuya Tagami; Akira Shimatsu; Tomoko Suzuki; Akiyo Tanabe; Mitsuhide Naruse
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

2.  Efficient screening of patients with aldosterone-producing adenoma using the ACTH stimulation test.

Authors:  Toshihiro Kita; Eiji Furukoji; Tatefumi Sakae; Kazuo Kitamura
Journal:  Hypertens Res       Date:  2019-01-08       Impact factor: 3.872

3.  Microvascular endothelial function is impaired in patients with idiopathic hyperaldosteronism.

Authors:  Shinji Kishimoto; Takeshi Matsumoto; Kenji Oki; Tatsuya Maruhashi; Masato Kajikawa; Shogo Matsui; Haruki Hashimoto; Yasuki Kihara; Farina Mohamad Yusoff; Yukihito Higashi
Journal:  Hypertens Res       Date:  2018-09-11       Impact factor: 3.872

4.  Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.

Authors:  Tetsuo Nishikawa; Masao Omura; Fumitoshi Satoh; Hirotaka Shibata; Katsutoshi Takahashi; Naohisa Tamura; Akiyo Tanabe
Journal:  Endocr J       Date:  2011-08-09       Impact factor: 2.349

5.  Use of the saline infusion test to diagnose the cause of primary aldosteronism.

Authors:  E Arteaga; R Klein; E G Biglieri
Journal:  Am J Med       Date:  1985-12       Impact factor: 4.965

6.  Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats.

Authors:  Akira Nishiyama; Li Yao; Yukiko Nagai; Kayoko Miyata; Masanori Yoshizumi; Shoji Kagami; Shuji Kondo; Hideyasu Kiyomoto; Takatomi Shokoji; Shoji Kimura; Masakazu Kohno; Youichi Abe
Journal:  Hypertension       Date:  2004-02-09       Impact factor: 10.190

7.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

Authors:  John W Funder; Robert M Carey; Franco Mantero; M Hassan Murad; Martin Reincke; Hirotaka Shibata; Michael Stowasser; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2016-03-02       Impact factor: 5.958

Review 8.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

9.  Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study.

Authors:  Sébastien Savard; Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Hypertension       Date:  2013-06-10       Impact factor: 10.190

10.  The number of positive confirmatory tests is associated with the clinical presentation and incidence of cardiovascular and cerebrovascular events in primary aldosteronism.

Authors:  Aya Saiki; Daisuke Tamada; Reiko Hayashi; Kosuke Mukai; Tetsuhiro Kitamura; Mitsuyoshi Takahara; Michio Otsuki; Iichiro Shimomura
Journal:  Hypertens Res       Date:  2019-03-08       Impact factor: 3.872

View more
  1 in total

1.  Reliability Analysis of a Functional Diagnostic Test for Primary Hyperaldosteronism Based on Data Analysis.

Authors:  Yan Wang; Jun Cai
Journal:  Comput Intell Neurosci       Date:  2022-06-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.